Figure 5.
Non-fatal serious adverse events (patients with at least one NF-SAE); Comparison of Cerebrolysin versus Placebo in the Safety Population, Random Effects, M-H, Risk Ratio (RR).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.